Why did MDG1.DE stock drop sharply in pre-market trade?

MDG1.DE stock fell on 07 Feb 2026 with heavy volume (189,470) that was roughly 4.39x the average. No matching company press release was found, so the move looks driven by large selling orders or position liquidation rather than a confirmed fundamentals event.

What short-term price target should traders use for MDG1.DE stock?

For an oversold bounce the realistic short-term target is EUR 0.20, with an extended bounce target at EUR 0.30. Set a stop below the intraday low (EUR 0.08) and scale out at defined profit points to manage risk.

How does Meyka AI view MDG1.DE stock in its grading system?

Meyka AI rates MDG1.DE with a score of 61.87/100 (Grade B, HOLD). The grade incorporates S&P 500 and sector comparisons, financial growth, key metrics, and analyst consensus. This is informational and not investment advice.

What is Meyka AI's short-term forecast for MDG1.DE stock?

Meyka AI's forecast model projects EUR 0.20 within three months versus the current price EUR 0.1335, implying an upside of roughly +49.8%. Forecasts are model-based and do not guarantee future results.

DE Stocks

Pre-market: MDG1.DE Medigene AG (XETRA) down 27% on 07 Feb 2026: oversold bounce setup

ByHuzaifa Zahoor February 7, 2026February 7, 2026

MDG1.DE stock opened sharply lower in pre-market trade after a heavy sell-off; the price is EUR 0.1335 following a -27.64% intraday move on 07 Feb 2026. Volume of 189,470 shares is about 4.39x average, signalling forced liquidation or a rapid repositioning. On XETRA in Germany, Medigene AG (MDG1.DE) now trades well below its 50-day average (EUR 1.41) and 200-day average (EUR 1.66). We view this as an oversold bounce candidate but stress heightened execution risk given weak fundamentals and a history of extreme downside